ProPhase Labs appoints Carolina Abenante as independent director effective June 20, 2025

ProPhase Labs, Inc.

Ms. Abenante will serve on Nominating and Corporate Governance Committee and as Chair of Compensation Committee.
Her term expires July 18, 2025, at the annual meeting; she is nominated for election to a full term.
She will be appointed to the Audit Committee effective July 19, 2025, subject to independence and financial literacy.
Ms. Abenante is founder of NYIAX and holds multiple law degrees; she receives $48,000 annual retainer and equity participation.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Carolina Abenante

independent director

PRPH · ProPhase Labs, Inc.

Effective: 2025-06-20
Filed: Jun 25, 2025 23:59 UTC

On June 20, 2025, the Board of Directors (the “Board”) of ProPhase Labs, Inc. (the “Company”) appointed Carolina Abenante, Esq. to serve as an independent director to fill the existing vacancy on the Board.

Source: SEC EDGAR

accession 0001641172-25-016501

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.